Wiki
-
-
-
-
-
- –
-
-
-
-
RADIATION ONCOLOGY CLINICAL TREATMENT PLANNING NOTE<br type=”_moz” />
<p class="MsoNormal“>Please refer to the radiation oncology consultation and simulation notes.
<p class="MsoNormal“>DIAGNOSIS: Cervical cancer stage IIB.
<p class="MsoNormal“>RATIONALE OF TREATMENT: The patient has known cervical cancer that is locally advanced. We explained to her about the indication of high-dose-rate brachytherapy treatment to try and achieve better local control of her cancer. We explained about high-dose-rate brachytherapy treatment and its potential side effects and complications, both short-term and long-term. The patient agreed on undergoing high-dose-rate brachytherapy treatment and signed an informed consent form.
<p class="MsoNormal“>TECHNICAL PLAN:
<p class="MsoNormal“>A. Special tests for tumor volume determination: A planning CT was done. We used the CT image as well as our physical examination for tumor volume determination.
<p class="MsoNormal“>B. Critical/sensitive organs at risk: Bladder, rectum, and small bowel.
<p class="MsoNormal“>C. Modality: We are planning to use high-dose-rate brachytherapy treatment with an Iridium-192 source.
<p class="MsoNormal“>D: Treatment time/dose considerations: We are planning to prescribe 6 Gy in 1 fraction to the tumor surface.
<p class="MsoNormal“>E. Ports: We are planning to treat the superior part of the vagina as well as the cervix and uterus using a tandem cylinder. We will also be using 25 dwelling source positions.
<p class="MsoNormal“>F. Devices: We will be using the Nucletron HDR unit.
+
RADIATION ONCOLOGY CLINICAL TREATMENT PLANNING NOTE
<p style=”" class=”MsoNormal”>Please refer to the radiation oncology consultation and simulation notes.
<p style=”" class=”MsoNormal”>DIAGNOSIS: Cervical cancer stage IIB.
<p style=”" class=”MsoNormal”>RATIONALE OF TREATMENT: The patient has known cervical cancer that is locally advanced. We explained to her about the indication of high-dose-rate brachytherapy treatment to try and achieve better local control of her cancer. We explained about high-dose-rate brachytherapy treatment and its potential side effects and complications, both short-term and long-term. The patient agreed on undergoing high-dose-rate brachytherapy treatment and signed an informed consent form.
<p style=”" class=”MsoNormal”>TECHNICAL PLAN:
<p style=”" class=”MsoNormal”>A. Special tests for tumor volume determination: A planning CT was done. We used the CT image as well as our physical examination for tumor volume determination.
<p style=”" class=”MsoNormal”>B. Critical/sensitive organs at risk: Bladder, rectum, and small bowel.
<p style=”" class=”MsoNormal”>C. Modality: We are planning to use high-dose-rate brachytherapy treatment with an Iridium-192 source.
<p style=”" class=”MsoNormal”>D: Treatment time/dose considerations: We are planning to prescribe 6 Gy in 1 fraction to the tumor surface.
<p style=”" class=”MsoNormal”>E. Ports: We are planning to treat the superior part of the vagina as well as the cervix and uterus using a tandem cylinder. We will also be using 25 dwelling source positions.
<p style=”" class=”MsoNormal”>F. Devices: We will be using the Nucletron HDR unit.
